What Does Octapharma Do?

Total employees2701
HeadquartersLachen
Founded1983

Octapharma is one of the largest human protein products manufacturers in the world, developing and producing high-quality human proteins from human plasma and human cell lines. As a family-owned company, Octapharma has been committed to patient care and medical innovation since its founding in 1983. The company's core business is the development, production, and sale of safe and effective human proteins for therapies in three areas: Haematology (coagulation disorders), Immunotherapy (immune disorders), and Critical Care (emergency medicine and intensive care). Octapharma owns state-of-the-art production plants in Austria, France, Germany, Mexico, and Sweden, and operates more than 190 plasma donation centres across Europe and the US.

Where Is Octapharma's Headquarters?

HQ Function

Serves as the global strategic command center, overseeing corporate management, financial operations, research and development direction, and international regulatory affairs for the Octapharma Group.

Notable Features:

Modern, purpose-built campus situated in Lachen, offering scenic views of Lake Zurich. The facility is designed to foster collaboration and innovation, reflecting the company's commitment to cutting-edge science and high-quality production.

Work Culture:

A highly international and collaborative environment, driven by scientific excellence and a strong patient-centric mission. Employees often highlight the company's family-owned stability, focus on quality, and commitment to long-term research and development.

HQ Significance:

Strategically located in Switzerland, a renowned hub for pharmaceuticals and biotechnology, providing access to specialized talent, robust infrastructure, and a stable regulatory environment. Its central European position facilitates effective global operations management and coordination.

Values Reflected in HQ: The headquarters' design, operations, and location emphasize precision, quality, innovation, and a commitment to sustainability, aligning with Octapharma's core values in developing life-saving human protein therapies.

Location:

Octapharma has a significant global footprint, distributing its life-saving therapies in approximately 118 countries worldwide. The company supports its international operations through 7 research and development facilities and 6 state-of-the-art manufacturing plants located in Austria, France, Germany, Mexico, and Sweden. Furthermore, Octapharma secures its plasma supply through its subsidiary Octapharma Plasma, Inc., which operates over 190 plasma donation centers in Europe and the United States.

Street Address:

Seidenstrasse 2

City:

Lachen

State/Province:

Schwyz

Country:

Switzerland

Where Else Does Octapharma Operate Around the World?

Vienna, Austria

Address: Oberlaaer Strasse 235, A-1100 Vienna

Serves as a critical site for innovation, production, and quality control within Octapharma's European and global manufacturing network.

Charlotte, NC, USA

Address: 11500 N. Community House Road, Charlotte, NC 28277

Manages and expands plasma collection operations in the U.S., ensuring a stable and high-quality supply of plasma for manufacturing life-saving therapies.

Stockholm, Sweden

Address: Lars Forssells gata 23, SE-112 15 Stockholm

Contributes to Octapharma's diverse product portfolio with specialized production capabilities and advanced R&D in the Nordic region.

Springe, Germany

Address: Elisabeth-Selbert-Straße 11, 31832 Springe

Enhances Octapharma's production capacity and expertise in Germany, a major market and pharmaceutical hub in Europe.

Buying Intent Signals for Octapharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Octapharma? Meet the Executive Team

As of April 2025, Octapharma' leadership includes:

Wolfgang Marguerre - Chairman
Tobias Marguerre - Co-CEO Octapharma AG & Member of the Board
Frédéric Marguerre - Co-CEO Octapharma AG & Member of the Board
Dr. Barbara Rangger - Chief Operating Officer (COO) & Member of the Executive Management Board
Roger Mächler - Chief Financial Officer (CFO) & Member of the Executive Management Board
Olaf Walter - Head of International Business Units & Member of the Executive Management Board
Dr. Andreas Woppmann - Head of Global Manufacturing & Supply Chain & Member of the Executive Management Board

Who's Investing in Octapharma?

Octapharma has been backed by several prominent investors over the years, including:

Privately Held - Family-Owned (Marguerre Family)

What Leadership Changes Has Octapharma Seen Recently?

Hire2
Exits0

In a significant leadership evolution, Octapharma AG appointed Tobias Marguerre and Frédéric Marguerre as Co-CEOs, effective January 1, 2024. Wolfgang Marguerre continues in his role as Chairman of the Octapharma Group. This change marks a new chapter in the company's leadership structure.

New Appointments:

Tobias Marguerre, Tobias Marguerre took on the role of Co-CEO for Octapharma AG, representing a key leadership appointment.
Frédéric Marguerre, Frédéric Marguerre assumed the position of Co-CEO for Octapharma AG, joining the top executive leadership.

What Technology (Tech Stack) Is Used byOctapharma?

Discover the tools Octapharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Octapharma Email Formats and Examples

Octapharma commonly uses the 'firstname.lastname' email format for its employees. This is a standard pattern observed in communications from the company.

firstname.lastname@octapharma.com

Format

jane.doe@octapharma.com

Example

90%

Success rate

What's the Latest News About Octapharma?

Octapharma Press ReleaseApril 23, 2024

Octapharma news title: Octapharma presents new data for wilate® at WFH 2024 World Congress highlighting commitment to people with von Willebrand disease

Octapharma announced the presentation of new data on wilate®, its von Willebrand factor/factor VIII concentrate, at the World Federation of Hemophilia (WFH) 2024 World Congress. The data supports the efficacy and safety of wilate® in treating von Willebrand disease....more

Octapharma Press ReleaseJanuary 16, 2024

Octapharma news title: Octapharma Group reports strong growth in 2023 and announces new Co-CEOs for Octapharma AG

Octapharma reported significant sales growth of 14.3% to €3.266 billion in 2023. The company also announced the appointment of Tobias Marguerre and Frédéric Marguerre as Co-CEOs of Octapharma AG, effective January 1, 2024, while Wolfgang Marguerre continues as Chairman....more

Octapharma Press ReleaseJune 6, 2023

Octapharma news title: Octapharma announces positive topline results from phase 3 trial of octagam® 10% in adults with dermatomyositis

Octapharma shared positive topline results from its ProDERM pivotal phase 3 clinical trial on octagam® 10% [Human Normal Immunoglobulin (IVIg)] for treating adults with dermatomyositis. The study met its primary endpoint, demonstrating significant improvement in patients treated with octagam® 10%....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Octapharma, are just a search away.